IP Verse

Arena Pharmaceuticals patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Arena Pharmaceuticals opposed by its competitors

Explore Arena Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3801459
Aug 7, 2024Methods Of Treating Conditions Related To The S1P1 Receptor4
EP3582814
May 1, 2024Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal Manifestations2
EP3860590
Jun 7, 2023Methods For The Treatment Of Scleroderma2
EP3310760
Oct 19, 2022Crystalline L-Arginine Salt Of (R)-2-(7-(4-Cyclopentyl-3-(Trifluoromethyl)Benzyloxy)-1,2,3,4-Tetrahydrocyclo-Penta[B]Indol-3-Yl)Acetic Acid(Compound1) For Use In Sipi Receptor-Associated Disorders2

Top competitors of Arena Pharmaceuticals

List of top competitors of Arena Pharmaceuticals based on patent oppositions.